Nystatin
證據等級: L4 | 預測適應症: 10 個
## 藥師評估報告
Nystatin:從抗真菌藥物到外陰陰道炎
一句話總結
Nystatin 是一種抗真菌藥物,通常用於治療由念珠菌引起的感染。 TxGNN 模型預測它可能對**外陰陰道炎 (Vulvovaginitis)** 有效, 目前有 **0 個臨床試驗**和 **20 篇文獻**支持這個方向。
快速總覽
| 項目 | 內容 |
|---|---|
| 原適應症 | 對革蘭氏陽性菌及陰性菌所引起之感染症 |
| 預測新適應症 | vulvovaginal candidiasis、vulvovaginitis、disease of orbital region、disease of orbital part of eye adnexa、cystic teratoma、spinal cord dermoid cyst、postmenopausal atrophic vaginitis、biotin metabolic disease、oral candidiasis、candidiasis |
| TxGNN 預測分數 | 99.92% |
| 證據等級 | L4 |
| 台灣上市 | ✓ 已上市 |
| 許可證數 | 20 張 |
| 建議決策 | Proceed with Guardrails |
預測適應症詳細分析
1. vulvovaginitis L4 99.92% 主要分析
為什麼這個預測合理?
目前缺乏詳細的作用機轉資料。根據已知資訊,Nystatin 是抗真菌藥物的一部分,
其成分在由念珠菌引起的感染症中的療效已被證實,機轉上可能適用於外陰陰道炎。
</p>
</details>
此預測基於藥物的作用機轉,與現有臨床證據方向一致。
臨床試驗
目前無針對此特定適應症的臨床試驗登記。
相關文獻
| PMID | 年份 | 類型 | 期刊 | 主要發現 |
|---|---|---|---|---|
| 25775428 | 2015 | Article | BMJ clinical evidence | Candidiasis (vulvovaginal). |
| 21774671 | 2011 | Article | Journal of women's health (200 | Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. |
| 4919155 | 1970 | Article | The Medical clinics of North A | Nystatin. |
| 12228137 | 2002 | Article | BMJ (Clinical research ed.) | Vulvovaginal candidiasis. |
| 39771534 | 2024 | Article | Pharmaceutics | Fluconazole-Resistant Vulvovaginal Candidosis: An Update on Current Management. |
| 11363911 | 1996 | Article | Journal of the International A | Candidiasis. |
| 21718579 | 2010 | Article | BMJ clinical evidence | Candidiasis (vulvovaginal). |
| 3873872 | 1985 | Article | American journal of obstetrics | Vaginitis. |
| 4601917 | 1974 | Article | The Medical clinics of North A | Vaginitis. |
| 8193418 | 1994 | Article | The Annals of pharmacotherapy | Metronidazole hypersensitivity. |
| 10470518 | 1999 | Article | Comprehensive therapy | Vulvovaginitis in healthy women. |
| 20406393 | 2011 | Article | Mycoses | In vitro fluconazole and nystatin susceptibility and clinical outcome in complic... |
| 32104010 | 2020 | Article | Infection and drug resistance | Antifungal Activity of ZnO Nanoparticles and Nystatin and Downregulation of SAP1... |
| 16047929 | 2005 | Article | Ceska gynekologie | ["Mixed" and "miscellaneous" vulvovaginitis: diagnostics and therapy of vaginal ... |
| 16620487 | 2005 | Article | Clinical evidence | Candidiasis (vulvovaginal). |
| 31969236 | 2019 | Article | Acta dermatovenerologica Croat | Effectiveness and Pharmacokinetic evaluation of Geonistin® (Oxytetracyline and N... |
| 37023426 | 2023 | Article | Journal of infection in develo | Comparison of tea tree oil 5%, tea tree oil 10%, and nystatin inhibition zones a... |
| 4584828 | 1973 | Article | The Journal of obstetrics and | A trial of clotrimazole and nystatin in vaginal moniliasis. |
| 19454049 | 2007 | Article | BMJ clinical evidence | Candidiasis (vulvovaginal). |
| 30359236 | 2018 | Article | BMC microbiology | Nystatin enhances the immune response against Candida albicans and protects the ... |
2. disease of orbital region L3 99.90%
臨床試驗(2 項)
| 試驗編號 | 階段 | 狀態 | 人數 | 主要發現 |
|---|---|---|---|---|
| NCT03178149 | PHASE1 | RECRUITING | 42 | A Phase 1b, Multicenter, Dose Escalation, Evaluation of Safety and Tolerability ... |
| NCT06637423 | PHASE1, PHASE2 | RECRUITING | 32 | A Phase 1/2 Open-label Clinical Study to Evaluate the Safety and Efficacy of Int... |
3. disease of orbital part of eye adnexa L5 99.89%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
4. cystic teratoma L5 99.88%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
5. spinal cord dermoid cyst L5 99.88%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
6. postmenopausal atrophic vaginitis L5 99.88%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
7. biotin metabolic disease L5 99.87%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
8. vulvitis L4 99.83%
相關文獻(20 篇)
| PMID | 年份 | 類型 | 期刊 | 主要發現 |
|---|---|---|---|---|
| 25775428 | 2015 | Article | BMJ clinical evidence | Candidiasis (vulvovaginal). |
| 21774671 | 2011 | Article | Journal of women's health (200 | Boric acid for recurrent vulvovaginal candidiasis: the clinical evidence. |
| 4919155 | 1970 | Article | The Medical clinics of North A | Nystatin. |
| 12228137 | 2002 | Article | BMJ (Clinical research ed.) | Vulvovaginal candidiasis. |
| 21718579 | 2010 | Article | BMJ clinical evidence | Candidiasis (vulvovaginal). |
| 3873872 | 1985 | Article | American journal of obstetrics | Vaginitis. |
| 4601917 | 1974 | Article | The Medical clinics of North A | Vaginitis. |
| 8193418 | 1994 | Article | The Annals of pharmacotherapy | Metronidazole hypersensitivity. |
| 20406393 | 2011 | Article | Mycoses | In vitro fluconazole and nystatin susceptibility and clinical outcome in complic... |
| 16620487 | 2005 | Article | Clinical evidence | Candidiasis (vulvovaginal). |
| 31969236 | 2019 | Article | Acta dermatovenerologica Croat | Effectiveness and Pharmacokinetic evaluation of Geonistin® (Oxytetracyline and N... |
| 37023426 | 2023 | Article | Journal of infection in develo | Comparison of tea tree oil 5%, tea tree oil 10%, and nystatin inhibition zones a... |
| 4584828 | 1973 | Article | The Journal of obstetrics and | A trial of clotrimazole and nystatin in vaginal moniliasis. |
| 19454049 | 2007 | Article | BMJ clinical evidence | Candidiasis (vulvovaginal). |
| 30359236 | 2018 | Article | BMC microbiology | Nystatin enhances the immune response against Candida albicans and protects the ... |
| 10470518 | 1999 | Article | Comprehensive therapy | Vulvovaginitis in healthy women. |
| 11188008 | 2000 | Article | Akusherstvo i ginekologiia | [Polygynax]. |
| 21918792 | 2012 | Article | Acta dermato-venereologica | Efficacy of fluconazole and nystatin in the treatment of vaginal Candida species... |
| 3510698 | 1986 | Article | CMAJ : Canadian Medical Associ | Vaginitis: current microbiologic and clinical concepts. |
| 37029724 | 2023 | Article | Journal of obstetrics and gyna | Miconazole for the treatment of vulvovaginal candidiasis. In vitro, in vivo and ... |
9. commissural lip fistula L5 99.83%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
10. osteoradionecrosis of the mandible L5 99.83%
目前尚無針對此適應症的專門臨床研究。此為 TxGNN 模型預測結果,需進一步驗證。
想進一步了解這個藥物的老藥新用潛力嗎?點擊下方按鈕,直接開啟 AI 助手進行分析。
Claude:點擊後會複製提問並開啟新視窗,請按 Ctrl+V(Mac: Cmd+V)貼上
ChatGPT:點擊後直接開啟並自動帶入提問
免責聲明
本報告僅供學術研究參考,不構成醫療建議。藥物使用請遵循醫師指示,切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。
最後審核:2026-02-20 | 審核者:TwTxGNN Research Team
本報告僅供學術研究參考,不構成醫療建議。藥物使用請遵循醫師指示,切勿自行調整用藥。任何老藥新用決策需經過完整的臨床驗證與法規審查。
最後審核:2026-02-20 | 審核者:TwTxGNN Research Team
歡迎分享您對本報告的看法、補充資訊或提出問題。討論內容會同步到 GitHub Discussions。 需要 GitHub 帳號才能留言。